The methyl group of naftifine (1) and butenafine (2) was replaced by an azo
lic nucleus to obtain the new compounds 3-8 which exhibit the characteristi
cs of both allylamine (or benzylamine) and azole antifungals. The title com
pounds were evaluated in vitro against several pathogenic fungi responsible
for human disease. Among these, compounds 5, 6, and 8 were found to inhibi
t the growth of dermatophytes with a potency comparable to that of naftifin
e. The synthetic sequence includes the preparation of aminoazole Schiff bas
es, reduction, and alkylation of the corresponding secondary amines.